Looks like you’re on the UK site. Choose another location to see content specific to your location

New Oral Treatment for Epilepsy and Bi-polar Disorder
The product makes titration dosage easier, provides precise and adaptable dosing, and has the potential to spare the NHS millions of pounds annually.
Lamotrigine Desitin 10mg/ml Oral Suspension is the first licensed Lamotrigine oral liquid medicine available in the UK, offering simple, accurate and flexible dosing for vulnerable patient groups with epilepsy and bi-polar disorder.
Desitin Lamotrigine 10 mg/ml Oral Suspension is the first licenced oral solution medication containing lamotrigine to be made accessible in the UK, which provides easy, precise, and adaptable dosage for at risk patients with bipolar and epilepsy.
To reduce the possibility of possibly fatal negative consequences, precise dosage and gradual titration are crucial. Dose increase is necessary every fortnight until the ideal dose is reached. Because Oral Suspension satisfies all dosage needs in one product, prescription and distributing will be simpler. It is especially helpful for elderly adults, kids over 48 months, and those with intellectual impairments who also have epilepsy.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard